Home > Financial Ratios > CAPLIN POINT LABORATORIES

CAPLIN POINT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
CAPLIN POINT LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CAPLIN POINT LABORATORIES
Please provide your vote to see the results

CAPLIN POINT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 24.4114.6823.0716.8520.14

What is the latest Core EBITDA Growth ratio of CAPLIN POINT LABORATORIES ?

The latest Core EBITDA Growth ratio of CAPLIN POINT LABORATORIES is 24.41 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202424.41
Mar202314.68
Mar202223.07
Mar202116.85
Mar202020.14

How is Core EBITDA Growth of CAPLIN POINT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 24.41
66.28
Mar2023 14.68
-36.37
Mar2022 23.07
36.91
Mar2021 16.85
-16.34
Mar2020 20.14 -

Other Financial Ratios of CAPLIN POINT LABORATORIES


Compare Core EBITDA Growth ratio of peers of CAPLIN POINT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CAPLIN POINT LABORATORIES ₹15,929.2 Cr 7.8% 4.4% 42.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr -1.2% -3.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -6.6% -12.4% 22.3% Stock Analytics
CIPLA ₹122,835.0 Cr 0.3% 1.2% -5.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 0.7% 9.1% 7.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 0.4% -2.8% -12.7% Stock Analytics


CAPLIN POINT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CAPLIN POINT LABORATORIES

7.8%

4.4%

42.3%

SENSEX

-0.6%

-2.8%

1.7%


You may also like the below Video Courses